Literature DB >> 23766853

Role of oxidative stress in the pathophysiology of pneumococcal meningitis.

Tatiana Barichello1, Jaqueline S Generoso, Lutiana R Simões, Samuel G Elias, João Quevedo.   

Abstract

Pneumococcal meningitis is a life-threatening disease characterized by an acute purulent infection affecting the pia mater, the arachnoid, and the subarachnoid spaces. Streptococcus pneumoniae crosses the blood-brain barrier (BBB) by both transcellular traversal and disruption of the intraepithelial tight junctions to allow intercellular traversal. During multiplication, pneumococci release their bacterial products, which are highly immunogenic and may lead to an increased inflammatory response in the host. Thus, these compounds are recognized by antigen-presenting cells through the binding of toll-like receptors. These receptors induce the activation of myeloid differentiation factor 88 (MyD88), which interacts with various protein kinases, including IL-1 receptor-associated kinase-4 (IRAK4), which is phosphorylated and dissociated from MyD88. These products also interact with tumor necrosis factor receptor-associated factor 6 dependent signaling pathway (TRAF6). This cascade provides a link to NF- κ B-inducing kinase, resulting in the nuclear translocation of NF- κ B leading to the production of cytokines, chemokines, and other proinflammatory molecules in response to bacterial stimuli. Consequently, polymorphonuclear cells are attracted from the bloodstream and then activated, releasing large amounts of NO(•), O2(•), and H2O2. This formation generates oxidative and nitrosative stress, subsequently, lipid peroxidation, mitochondrial damage, and BBB breakdown, which contributes to cell injury during pneumococcal meningitis.

Entities:  

Mesh:

Year:  2013        PMID: 23766853      PMCID: PMC3665263          DOI: 10.1155/2013/371465

Source DB:  PubMed          Journal:  Oxid Med Cell Longev        ISSN: 1942-0994            Impact factor:   6.543


1. Introduction

Pneumococcal meningitis is the most complex and serious infection of the central nervous system (CNS) that is associated with neurological sequelae [1]. The host immune response, through the production of cytokines and chemokines and the migration of leukocytes, is the first line of defense in response to bacterial infection [2]. In addition, polymorphonuclear leukocytes produce nitric oxide (NO•), superoxide anion radicals (O2 −•), and hydrogen peroxide (H2O2). O2 −• and NO• can lead to the formation of peroxynitrite (ONOO), which is a strong oxidant [3]. This oxidant exerts cytotoxic effects on endothelial cells [4], increases the permeability of the BBB, induces the peroxidation of lipids, and induces many other complex interactions that seem to be involved in the pathophysiology of pneumococcal meningitis [3]. The aim of this review is to summarize the current knowledge of the relevant pathophysiological steps of pneumococcal meningitis: (a) the crossing of the pneumococcus through the BBB; (b) the activation of innate immune system mechanisms; (c) the migration of leukocytes and (d) the induction of oxidative and nitrosative stress in the context of pneumococcal meningitis.

2. Microbial Traversal of the Blood-Brain Barrier

The CNS is protected by a bony skull, the leptomeninges, the blood-brain barrier (BBB), and the blood-cerebrospinal fluid barrier [5]. The BBB is formed by microvascular endothelial cells, astrocytes, and pericytes. This barrier acts by controlling the exchange of substances into and out of the brain [6] and thereby protects the brain from toxins and pathogens [5]. S. pneumoniae crosses the BBB through both transcellular traversal and paracellular traversal [6, 7]. In transcellular traversal, the pathogen interacts with cell-wall phosphorylcholine and the platelet-activating-factor (PAF) receptor. In addition, the protein C (PspC) pneumococcal surface binds to both the laminin receptor and the polymeric Ig receptor (pIgR), which are located on brain microvascular endothelial cells [8]. Later, the pathogen transmigrates through endothelial cells to the basolateral side without any evidence of disruption of intercellular tight junctions [5, 6]. Paracellular traversal involves the penetration of bacteria between barrier cells with or without evidence of tight-junction disruption [6]. Both the host immune response and bacterial virulence factors, such as pneumolysin, and the ability of pneumococci to bind to fibronectin [9], vitronectin, and collagen in the extracellular matrix, act together to increase the permeability of the BBB [10, 11]. This interaction facilitates the passage of the microorganism into the brain [1] Figure 1.
Figure 1

Mechanisms of microbial traversal of the BBB. S. pneumoniae crosses the BBB through transcellular traversal and paracellular traversal.

3. Innate Immune Mechanisms of the Pneumococcal Meningitis

After S. pneumoniae reaches the subarachnoid space, it multiplies rapidly and releases compounds, such as cell wall fragments, lipoteichoic acid, teichoic acid, pneumolysin, and peptidoglycan [1]. These compounds are highly immunogenic and may elicit an inflammatory response in the host. These immunogenic molecular determinants are better known as pathogen-associated molecular patterns (PAMPs) [12, 13]. These PAMPs are recognized by different sensors of the innate immune system called pattern recognition receptors (PRRs) [14]. These PRRs comprise toll-like receptors (TLRs), NOD-like receptors (NLRs), and DNA sensors [14, 15]. At present, there are 13 members of the TLR family described in humans and 10 described in mice. These members are separated into two broad categories. One category is expressed at the cell surface for extracellular ligand recognition. The other category is localized in the endosomal compartment for the recognition of pathogen nucleic acids [16]. Microglia express all TLRs identified to date, whereas astrocytes only express TLR1, TLR2, TLR3 and TLR9. Neurons only express TLR3, TLR7, TLR8, and TLR9, and oligodendrocytes only express TLR2 and TLR3 [15, 17]. TLR2 is activated by pneumococcal cell wall compounds, lipoteichoic acid, and lipoproteins. TLR4 is activated by pneumolysin, and TLR9 is activated by pneumococcal DNA containing CpG motifs within endosomes [14, 15]. TLR2, TLR4, and TLR9 transduce their signals through a common intracellular adapter protein known as myeloid differentiation factor 88 (MyD88) [14, 18]. Of note, the deficiency of this intracellular adapter protein in children increases their susceptibility to invasive pneumococcal infections, including meningitis [19]. MyD88 interacts with a protein kinase, IL-1 receptor-associated kinase-4 (IRAK4) [1, 20]. The IRAK4 dependent, TLRs, and IL-1Rs are vital for childhood immunity to pyrogenic bacteria, which are mainly invasive pneumococcal infections [21]. After IRAK has been phosphorylated, it is dissociated from MyD88 and interacts with tumor necrosis factor receptor-associated factor 6 dependent signaling pathway (TRAF6) [22]. TRAF6 stimulates the transforming growth factor β-activated kinase (TAK1), which is a MAPKKK. Thus, TAK1 activates IKK (Inhibitor of IkB kinase), which results in the destruction of IkB and the subsequent activation and nuclear translocation of NF-κB [23, 24]. NF-κB comprises a closely related family of transcription factors, which play a key role in the expression of genes involved in the development of accessory cell and leukocyte populations, inducing the expression of many proteins implicated in inflammation and in the immune response [25]. NF-κB is also a transcriptional activator of various genes implicated in neuronal pathogenesis and in the production of cytokines and chemokines [20, 26]. The nucleotide-binding-oligomerization-domains-NOD-like receptors (NLRs) are also involved in the recognition of S. pneumoniae by the innate immune system. The family members consist of intracellular receptors, such as inflammasome-forming proteins (NLRPs), NLRP1, NLRP3, and NLRP6, which mediate the assembly of inflammasome complexes leading to the activation of procaspase-1. The second group of NLRs includes intracellular recognition receptors, such as NOD1/CARD4 and NOD2/CARD15. These receptors mediate the assembly of complexes that activate MAPK and NF-κB signaling pathways, and they are involved in the detection of cell wall peptidoglycan [27, 28]. NLRP3 (cryopyrin) and AIM2 (absent in melanoma 2) inflammasomes are activated by pneumolysin and bacterial DNA. These inflammasomes use an adapter molecule, known as apoptosis-associated speck-like protein (ASC), which is a key component of multimeric protein complexes that mediate inflammation and host defenses [29]. NLRP3 and AIM2 promote caspase-1 activation and the subsequent conversion of pro-IL-1β into mature IL-1β in pneumococcal meningitis [30]. Furthermore, pneumolysin activates the NLRP3 inflammasome and promotes the production of the proinflammatory cytokines independently of TLR4 [31], Figure 2.
Figure 2

Innate immune system in pneumococcal meningitis infection. The majority of TLRs utilize a common intracellular adapter protein known as myeloid differentiation factor 88 (MyD88): it activates IRAK, which is phosphorylated and dissociated from MyD88. Thus, it interacts with the tumor necrosis factor receptor-associated factor 6 dependent signaling pathway (TRAF6). TRAF6 stimulates to the transforming growth factor β-activated kinase (TAK1). TAK1 activates the IKK (Inhibitor of IκB kinase), resulting in the destruction of IkB and subsequently, NF-κB activation resulting in the nuclear translocation of NF-κB. This cascade provides a link to NF-κB-inducing kinase, resulting in the nuclear translocation of NF-κB, which induces the production of cytokines, chemokines, and others proinflammatory molecules in response to bacterial stimuli.

4. Leukocyte Migration

Pneumococcal compounds are proinflammatory mediators that induce an innate immune response that activates NF-κB and subsequently triggers the production of proinflammatory cytokines and chemokines and the expression of co-stimulatory molecules [32]. In response, neutrophils leave the blood and migrate to sites of infection. Sialyl-LewisX on leukocytes binds to selectins P and E on endothelial cells. This binding becomes stronger when CXCL-8 binds to its specific receptor on neutrophils, which triggers the production of integrin LFA-1 and CX3 (mac-1). Inflammatory cytokines, such as TNF-α, are also necessary to induce expression of adhesion molecules ICAM-1 and ICAM-2. The link between endothelial cells and ICAM-1 allows the passage of neutrophils along a gradient of chemoattractants substances [33, 34], Figure 3. Consistent with the polymorphonuclear migration, as explained previously, TNF-α is produced mainly in the first 6 to 24 hours after pneumococcal meningitis induction [35]. Patients with bacterial meningitis also have increased the levels of TNF-α in the CSF early in the course of the disease [36]. In bacterial meningitis, approximately 90% of the migrating leukocytes are neutrophilic granulocytes [37]. However, blocking the accumulation of leukocytes in cerebrospinal fluid augments bacteremia and lethality in experimental pneumococcal meningitis [38].
Figure 3

Leukocyte migration. Leukocytes leave the blood and migrate to sites of infection. Sialyl-LewisX on leukocytes binds to selectins P and E on endothelial cells. This binding becomes stronger when CXCL-8 binds to its specific receptor on neutrophils, triggering the production of integrin LFA-1 and CX3 (mac-1). Inflammatory cytokines, such as TNF-α, are also necessary to induce expression of the adhesion molecules ICAM-1 and ICAM-2. The interaction between endothelial cells and ICAM-1 allows the passage of neutrophils along a gradient of chemoattractants substances.

Initially, phagocytized pathogens are internalized in the phagosome. The phagosome is acidified by fusion with lysosomes, becoming a phagolysosome. In this period, high amounts of reactive oxygen species (ROS) and reactive nitrogen species (RNS) are formed [39]. The relevant antimicrobial systems of phagocytic cells are the NADPH phagocytic oxidase and inducible nitric oxide synthase (iNOS) pathways, which are expressed in neutrophil and macrophage cells [40]. Macrophages and neutrophils produce NO•, O2 −•, and H2O2. NO• is produced by iNOS2, and O2 −• is produced by NADPH oxidase. O2 −• and NO• can lead to the formation of ONOO− [3], which is a strong oxidant that exerts cytotoxic effects on endothelial and vascular smooth muscle cells [4]. Moreover, chemical and enzymatic reactions produce a variety of toxic chemical agents; O2 −• is converted by the enzyme superoxide dismutase (SOD) into H2O2 [38, 39]. H2O2 can kill the microorganisms and also be converted by the peroxidase enzyme in the presence of Fe2+ into hypochlorite (OCl−) and hydroxyl radicals (•OH), which are microbicides [3, 39, 41].

5. Oxidative Stress in the Context of Pneumococcal Meningitis

During pneumococcal meningitis, RNS and ROS are produced by resident immune cells of the brain as part of the host response to invasive bacterial infections [1, 42]. Furthermore, ROS are produced in greater quantities in neutrophils than in macrophages; however, macrophages produce more RNS than neutrophils [43]. S. pneumoniae also produces H2O2, which interacts with NO• forming ONOO− [44, 45]. ONOO− can damage neurons and glial cells by lipid peroxidation and cell membrane destabilization; it can also cause DNA disintegration and subsequent poly (ADP-ribose) polymerase (PARP) activation, which leads to cell energy reduction and cell death [2]. In pneumococcal meningitis, adjuvant therapy with an ONOO− scavenger reduces the number of CSF leukocytes concentrations and reduces the brain concentrations of IL-1β and MIP-2 [46]. This reduction is associated with a decrease of the number of leukocytes in the CSF, suggesting the involvement of ROS/RNS and proinflammatory cytokines and chemokines in the attraction of leukocytes from the blood into the subarachnoid space [3]. ONOO− can contribute to the development of meningeal inflammation and increase the production of IL-8. This chemokine is equivalent to rat MIP-2; it is a chemoattractant and is involved in the migrations of leukocytes in pneumococcal meningitis [47]. In addition, treatment with a monoclonal antibody that binds with IL-8 attenuates pleocytosis in experimental pneumococcal meningitis in rabbits [48]. In vitro, the production of cytokines by human mononuclear cells was regulated by ONOO−. This activation was mediated via the transcription factor NF-κB by a mechanism that may involve nitration or dephosphorylation of IκB-a which leads to NF-κB translocation and release of TNF-α [49]. One of the major and first pathologies during pneumococcal meningitis is the breakdown of the BBB. In an animal model, the BBB breakdown occurred at 12 hours after pneumococcal meningitis induction [50], subsequent to the cytokine production [35]. ROS and RNS have been implicated as mediators of the BBB breakdown [3], suggesting that the increase of the BBB permeability appears to be related to the presence of NO• and O2 −• [51]. Furthermore, treatment with antioxidant prevented BBB disruption [41, 46]. Neurological sequelae from pneumococcal meningitis are estimated to occur in 30 to 52% of surviving patients [1, 52]. This damage has been demonstrated in a bacterial meningitis animal model; in this model, the surviving animals showed memory and learning impairment, depressive-like-behaviors, and anxiety-like symptoms [53]. In addition, coadjuvant treatment with antioxidants prevented cognitive impairment and oxidative stress in the brain of the survivor rats of the bacterial meningitis animal model [54]. ROS and RNS are related to these cognitive sequelae because of the cellular damage that they cause. The nervous system is a unique network of diverse cell types, comprising multiple proteins, lipids, and carbohydrates, and has important interactions with all major organs in the body [55]. Thus, the brain becomes particularly vulnerable to oxidative damage due to its high oxygen consumption, the abundance of iron, relatively low expression of antioxidants levels [55], and high presence of the polyunsaturated fatty acids [3]. H2O2 and pneumolysin produced by pneumococcus can cause neuronal cell death through mitochondrial damage [45, 56], leading to the release of apoptosis-inducing factor (AIF) into the cytosol and subsequently inducing apoptosis by a caspase-independent pathway [56]. Furthermore, leukocytes activate the tumor suppressor protein (p53) and the ataxia telangiectasia-mutated (ATM) kinase, which induce mitochondria to release cytochrome-c. Cytochrome-c, Apaf-1, and dATP/ATP are needed to form the apoptosome which is a special protein complex. Subsequently, apoptosome activates the caspase-9, that results in the activation of caspase-3 and apoptosis [56, 57]. The formation of ROS can cause direct damage through lipid peroxidation and carbonylation. Lipid peroxidation can be increased in serum [58] and in the CSF of children with bacterial meningitis [59].

6. Conclusion

Understanding the interactions between the complex immune network, composed of cytokines, chemokine, leukocytes, and oxidative stress, and bacterial virulence factors may help to establish more effective therapeutic strategies for CNS infections and, therefore, a better outcome for affected subjects.
  59 in total

1.  Oxidant and antioxidant parameters in the treatment of meningitis.

Authors:  Ali Aycicek; Akin Iscan; Ozcan Erel; Mustafa Akcali; Ali Riza Ocak
Journal:  Pediatr Neurol       Date:  2007-08       Impact factor: 3.372

Review 2.  Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy?

Authors:  Matthias Klein; Uwe Koedel; Hans-Walter Pfister
Journal:  Prog Neurobiol       Date:  2007-01-09       Impact factor: 11.685

3.  Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.

Authors:  Christian T Brandt; Jens D Lundgren; Niels Frimodt-Møller; Thomas Christensen; Thomas Benfield; Frank Espersen; David M Hougaard; Christian Ostergaard
Journal:  J Neuroimmunol       Date:  2005-09       Impact factor: 3.478

Review 4.  Ubiquitin-mediated activation of TAK1 and IKK.

Authors:  A Adhikari; M Xu; Z J Chen
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

Review 5.  Signaling to NF-kappaB by Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Trends Mol Med       Date:  2007-10-29       Impact factor: 11.951

Review 6.  Microbial translocation of the blood-brain barrier.

Authors:  Kwang Sik Kim
Journal:  Int J Parasitol       Date:  2006-03-06       Impact factor: 3.981

Review 7.  Mechanisms of microbial traversal of the blood-brain barrier.

Authors:  Kwang Sik Kim
Journal:  Nat Rev Microbiol       Date:  2008-07-07       Impact factor: 60.633

8.  Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation.

Authors:  Shereen Shoma; Kohsuke Tsuchiya; Ikuo Kawamura; Takamasa Nomura; Hideki Hara; Ryosuke Uchiyama; Sylvia Daim; Masao Mitsuyama
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

9.  TfR1 interacts with the IKK complex and is involved in IKK-NF-κB signalling.

Authors:  Niall S Kenneth; Sharon Mudie; Sanne Naron; Sonia Rocha
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

10.  Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.

Authors:  Cheng-Lung Ku; Horst von Bernuth; Capucine Picard; Shen-Ying Zhang; Huey-Hsuan Chang; Kun Yang; Maya Chrabieh; Andrew C Issekutz; Coleen K Cunningham; John Gallin; Steven M Holland; Chaim Roifman; Stephan Ehl; Joanne Smart; Mimi Tang; Franck J Barrat; Ofer Levy; Douglas McDonald; Noorbibi K Day-Good; Richard Miller; Hidetoshi Takada; Toshiro Hara; Sami Al-Hajjar; Abdulaziz Al-Ghonaium; David Speert; Damien Sanlaville; Xiaoxia Li; Frédéric Geissmann; Eric Vivier; László Maródi; Ben-Zion Garty; Helen Chapel; Carlos Rodriguez-Gallego; Xavier Bossuyt; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  14 in total

1.  Differential Gene Expression Associated with Meningeal Injury in Acute Mild Traumatic Brain Injury.

Authors:  Whitney S Livingston; Jessica M Gill; Martin R Cota; Anlys Olivera; Jessica L O'Keefe; Christiana Martin; Lawrence L Latour
Journal:  J Neurotrauma       Date:  2016-08-30       Impact factor: 5.269

2.  Association between Experimental Bacterial Meningitis and Periapical Lesion.

Authors:  Tatiana Barichello; Soraia Netto; Renan Antonio Ceretta; Jaqueline S Generoso; Lutiana R Simões; Patrícia Ávila Ribeiro; Josiane Budni; João Quevedo
Journal:  J Clin Diagn Res       Date:  2015-05-01

Review 3.  Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Lutiana R Simões; Jessica A Goularte; Fabricia Petronilho; Priyanka Saigal; Marwa Badawy; João Quevedo
Journal:  Mol Neurobiol       Date:  2015-03-07       Impact factor: 5.590

4.  Folic acid prevented cognitive impairment in experimental pneumococcal meningitis.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Lutiana R Simões; Amanda V Steckert; Ana Paula Moreira; Diogo Dominguini; Pâmela Ferrari; Carolina Gubert; Flávio Kapczinski; Luciano K Jornada; Lucineia G Danielski; Fabricia Petronilho; Josiane Budni; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2014-09-19       Impact factor: 3.575

5.  SKAP2 suppresses inflammation-mediated tumorigenesis by regulating SHP-1 and SHP-2.

Authors:  Kurara Takagane; Michinobu Umakoshi; Go Itoh; Sei Kuriyama; Akiteru Goto; Masamitsu Tanaka
Journal:  Oncogene       Date:  2022-01-17       Impact factor: 9.867

6.  Reactive oxygen species and nitric oxide as mediators in plant hypersensitive response and stomatal closure.

Authors:  Yingjun Liu; Huajian Zhang
Journal:  Plant Signal Behav       Date:  2021-10-20

Review 7.  The blood-brain barrier dysfunction in sepsis.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Allan Collodel; Fabricia Petronilho; Felipe Dal-Pizzol
Journal:  Tissue Barriers       Date:  2020-12-15

Review 8.  Pathogenic Triad in Bacterial Meningitis: Pathogen Invasion, NF-κB Activation, and Leukocyte Transmigration that Occur at the Blood-Brain Barrier.

Authors:  Shifu Wang; Liang Peng; Zhongtao Gai; Lehai Zhang; Ambrose Jong; Hong Cao; Sheng-He Huang
Journal:  Front Microbiol       Date:  2016-02-19       Impact factor: 5.640

9.  Role of neural barriers in the pathogenesis and outcome of Streptococcus pneumoniae meningitis.

Authors:  Ofer Prager; Alon Friedman; Yaffa Mizrachi Nebenzahl
Journal:  Exp Ther Med       Date:  2017-01-24       Impact factor: 2.447

10.  Competence-induced protein Ccs4 facilitates pneumococcal invasion into brain tissue and virulence in meningitis.

Authors:  Yujiro Hirose; Masaya Yamaguchi; Kana Goto; Tomoko Sumitomo; Masanobu Nakata; Shigetada Kawabata
Journal:  Virulence       Date:  2018       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.